BlackRock Technology and Private Equity Term Trust (BTX) P/E Ratio History
Insufficient DataInsufficient historical P/E data to classify valuation. · Data 2026–2026
Loading P/E history...
P/E Ratio Analysis
Compared to the Healthcare sector median P/E of 23.5x, BTX trades at a 117% premium to its sector peers. The sector includes 231 companies with P/E ratios ranging from 0.0x to 199.4x.
Relative to the broader market, BTX commands a significant premium over the S&P 500 median P/E of 25.6x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our BTX DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
BTX Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
BTX P/E vs Peers
Royalty and IP Monetization Vehicles peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $3B | 9.1 | 0.29Best | +4% | |
| $3B | 8.7 | - | +15% | |
| $194M | 3.9Lowest | 3.87 | +49% | |
| $1B | 8.9 | - | +87%Best | |
| $157B | 28.5 | 13.29 | -16% | |
| $2.9T | 28.4 | 1.51 | +16% | |
| $4.6T | 41.9 | 2.35 | +23% | |
| $4.7T | 39.9 | 0.42 | +67% | |
| $4.4T | 33.9 | 1.14 | +34% | |
| $1.5T | 25.6 | 1.39 | -2% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
10-year return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BTX — Frequently Asked Questions
Quick answers to the most common questions about buying BTX stock.
What is BTX's P/E ratio?
BlackRock Technology and Private Equity Term Trust (BTX) trailing twelve-month P/E ratio is 51.1x, based on TTM diluted EPS of N/A. The 5-year average P/E is N/A and the historical range spans N/A to N/A.
Is BTX stock overvalued or undervalued?
BTX current P/E: 51.1x. 5-year average P/E: N/A. Percentile: N/A.
Is BTX stock expensive?
BTX is fairly valued relative to its own history. The current P/E of 51.1x is near the 5-year average of N/A (N/A percentile of historical range).
What is BTX's historical P/E range?
Over the past 5 years, BTX's P/E ratio has ranged from N/A to N/A, with a median of N/A and an average of N/A. The current P/E of 51.1x places the stock at the N/A percentile of this range. Full historical data spans 2026–2026.
How does BTX's P/E compare to the S&P 500?
BTX trades at 51.1x P/E versus the S&P 500 median of 25.6x. The 100% premium to the market typically reflects higher expected earnings growth or quality.
How does BTX's valuation compare to Healthcare peers?
BlackRock Technology and Private Equity Term Trust P/E of 51.1x compares to the Healthcare sector median of 23.5x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is BTX's PEG ratio?
BTX PEG ratio is N/A, based on a P/E of 51.1x and EPS growth of -82.7%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is BTX's earnings yield?
BTX earnings yield is 1.96%, the inverse of its 51.1x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.